medmix AG (MEDX) - Total Liabilities
Based on the latest financial reports, medmix AG (MEDX) has total liabilities worth CHF536.50 Million CHF (≈ $678.28 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check medmix AG asset resilience ratio to evaluate the company's liquid asset resilience ratio.
medmix AG - Total Liabilities Trend (2018–2025)
This chart illustrates how medmix AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MEDX current and non-current assets.
medmix AG Competitors by Total Liabilities
The table below lists competitors of medmix AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INPAQ Technology Co Ltd
TWO:6284
|
Taiwan | NT$6.22 Billion |
|
GuangZhou Wahlap Technology Corporation Limited
SHE:301011
|
China | CN¥574.54 Million |
|
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
|
China | CN¥202.03 Million |
|
Archer Ltd.
LSE:0RBA
|
UK | Nkr735.20 Million |
|
Third Point Investors Limited
LSE:TPOU
|
UK | $2.02 Million |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
USA | $451.42 Million |
|
Camping World Holdings Inc
NYSE:CWH
|
USA | $4.52 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down medmix AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is medmix AG's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.61 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how medmix AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for medmix AG (2018–2025)
The table below shows the annual total liabilities of medmix AG from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CHF536.50 Million ≈ $678.28 Million |
+5.71% |
| 2024-12-31 | CHF507.50 Million ≈ $641.62 Million |
-4.68% |
| 2023-12-31 | CHF532.40 Million ≈ $673.10 Million |
-11.43% |
| 2022-12-31 | CHF601.10 Million ≈ $759.95 Million |
+36.46% |
| 2021-12-31 | CHF440.50 Million ≈ $556.91 Million |
-3.50% |
| 2020-12-31 | CHF456.50 Million ≈ $577.14 Million |
+13.59% |
| 2019-12-31 | CHF401.90 Million ≈ $508.11 Million |
+6.21% |
| 2018-12-31 | CHF378.40 Million ≈ $478.40 Million |
-- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more